Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...

We explore the complexities of navigating share option plans on both sides of the Atlantic. For companies looking to reward employees...

On Wednesday 11 June 2025, Bristows had the privilege of hosting a BioWednesday event in conjunction with One Nucleus and the Cell and...

This article was first published in the Bio-science Law Review (Volume 19, Issue 6) by Lawtext Publishing. Cell and Gene Therapies...

On 18 March 2025, Bristows attended the Wired Health 2025 conference, which took place at Kings Place in London. It was a day gathering...

As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...

Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...

Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...

This article was first published in The Licensing Journal (Volume 44, Number 4). You can read and/or download it, in full, below: Cell...

Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...